Protext Mobility, Inc. (OTC: TXTM) Announces Plans for Corporate Website Redesign and Investor Relations Suite to Enhance Transparency and Shareholder Engagement GlobeNewswire October 17, 2025 NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Protext Mobility, Inc. (OTC: TXTM), an emerging leader in botanical-based biotechnology, today announced its strategic initiative to redesign its corporate website and […]

(NasdaqGM:LFMD), NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming Deadlines – LFMD GlobeNewswire October 17, 2025 NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ:

(NASDAQ:JSPR), NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) and certain officers.   The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-08010, is on

(NasdaqGM:PUBM), NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against PubMatic, Inc. (“PubMatic” or the “Company”) (NASDAQ: PUBM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include

(NYSE:AI), NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. (“C3” or the “Company”) (NYSE: AI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include

Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers – JSPR GlobeNewswire October 17, 2025 NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Jasper Therapeutics, Inc. (“Jasper” or the “Company”) (NASDAQ: JSPR) and certain officers.  

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PubMatic, Inc. of Class Action Lawsuit and Upcoming Deadlines – PUBM GlobeNewswire October 17, 2025 NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against PubMatic, Inc. (“PubMatic” or the “Company”) (NASDAQ:

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in C3.ai, Inc. of Class Action Lawsuit and Upcoming Deadlines – AI GlobeNewswire October 17, 2025 NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against C3.ai, Inc. (“C3” or the “Company”) (NYSE:

(NYSE:FLR), NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Fluor Corporation (“Fluor” or the “Company”) (NYSE: FLR) and certain officers.   The class action, filed in the United States District Court for the Northern District of Texas, Dallas Division, and docketed under 25-cv-02496, is